i-spero® brings together decades of clinical research and proven artificial intelligence to deliver digital tools that improve recovery rates for patients whilst reducing the overall cost of treatment.
i‑spero® will be used as a part of Low mood, depression and anxiety walk in clinic in Faversham.
P1vital Products (PPL) has, in partnership with Canterbury and Coastal CCG, University of Kent, and the mental health charity MIND, been awarded £815,506 by the UK’s innovation agency, Innovate UK, to advance research to improve the treatment of depression.
New article on predicting antidepressant treatment response was published in November issue of European Neuropsychopharmacology
We are pleased to announce that P1vital Products Ltd was awarded Innovate UK Grant.